Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lucentis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

Bayer's Eylea data not suitable, says IQWiG

Bayer's Eylea data not suitable, says IQWiG German HTA body unhappy with Lucentis comparison data and turns down Bayer-Regeneron wet AMD drug. ... drug was superior to Novartis' Lucentis (ranibizumab) in the treatment of wet age-related macular degeneration (AMD).

Novartis, Roche under scrutiny in Italy on Avastin/Lucentis collusion claims

Novartis, Roche under scrutiny in Italy on Avastin/Lucentis collusion claims The active ingredients in both medicines were developed by Roche subsidiary Genentech, with Novartis marketing Lucentis under license in Europe. ... as the publicly-funded CATT and IVAN trials - which found the drug was as effective as Lucentis.

Novartis’ Jakavi turned down by NICE for blood cancer

Novartis’ Jakavi turned down by NICE for blood cancer UK cost-effectiveness watchdog concerned about 'uncertainties' in data in draft guidance

Novartis expects tough 2013 before a return to growth

Novartis expects tough 2013 before a return to growth However, Novartis expects growth in its portfolio of new treatments, including Lucentis, Gilenya, Afinitor and Tasigna, to allow it to report sales growth of at least mid-single digits in 2014

NICE set to approve Novartis eye drug Lucentis

NICE set to approve Novartis eye drug Lucentis Patients in England will soon have access to Novartis' Lucentis after it was finally deemed a cost-effective use of NHS resources as a treatment for the eye condition diabetic macular ... new final draft guidance puts Lucentis on course for a second

[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics